OTCMKTS:CPMD CannaPharmaRX (CPMD) Stock Price, News & Analysis $0.0044 0.00 (0.00%) As of 06/9/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock About CannaPharmaRX Stock (OTCMKTS:CPMD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CannaPharmaRX alerts:Sign Up Key Stats Today's Range$0.0044▼$0.004450-Day Range N/A52-Week Range$0.0001▼$0.0175VolumeN/AAverage Volume188,005 shsMarket Capitalization$2.91 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.Read More… Receive CPMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter. Email Address CPMD Stock News HeadlinesContrasting CannaPharmaRX (OTCMKTS:CPMD) & Pacira BioSciences (NASDAQ:PCRX)June 8 at 1:41 AM | americanbankingnews.comCannapharmaRX Updates on Alberta Facility Progress and International Export StrategyDecember 4, 2024 | finance.yahoo.comElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly becoming one of the most profitable stories of the year.June 11, 2025 | True Market Insiders (Ad)PSIQ Profile Solutions, Inc.August 16, 2024 | seekingalpha.comCannaPharmaRX, Inc. (CPMD)May 22, 2024 | finance.yahoo.comCannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference CallMay 20, 2024 | finance.yahoo.comCannapharmarx, Inc.: CannapharmaRx Receives First Purchase Order and Begins Shipment of ProductMarch 14, 2024 | finanznachrichten.deSee More Headlines CPMD Stock Analysis - Frequently Asked Questions How have CPMD shares performed this year? CannaPharmaRX's stock was trading at $0.0081 at the start of the year. Since then, CPMD shares have decreased by 45.7% and is now trading at $0.0044. View the best growth stocks for 2025 here. How were CannaPharmaRX's earnings last quarter? CannaPharmaRX, Inc. (OTCMKTS:CPMD) issued its earnings results on Thursday, April, 10th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $0.48 million during the quarter. How do I buy shares of CannaPharmaRX? Shares of CPMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CannaPharmaRX own? Based on aggregate information from My MarketBeat watchlists, some other companies that CannaPharmaRX investors own include FuelCell Energy (FCEL), Blackstone (BX), Global Helium (HECOF), Trillium Therapeutics (TRIL), AFC Gamma (AFCG) and American Lithium (AMLI). Company Calendar Last Earnings4/10/2025Today6/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:CPMD CIK1081938 Webwww.cannapharmarx.com Phone(949) 652-6838Fax720-875-1905Employees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$3.69 million Net MarginsN/A Pretax Margin408.11% Return on EquityN/A Return on Assets-41.99% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.03) per share Price / Book-0.15Miscellaneous Outstanding Shares660,626,000Free Float652,236,000Market Cap$2.91 million OptionableNot Optionable Beta2.41 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:CPMD) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CannaPharmaRX, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CannaPharmaRX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.